Results 161 to 170 of about 10,559 (201)

Therapeutic targeting of Aurora Kinase A in advanced prostate cancer. [PDF]

Serican J Med
Zerdan MB, Bilen MA, Yu J.
europepmc   +1 more source

Macrophage migration inhibitory factor (MIF) and the tumor ecosystem: a tale of inflammation, immune escape, and tumor growth. [PDF]

Front Immunol
Youness RA, Elemam NM, Abdelhamid AM, Mohamed AH, Elsherbiny LM, Ramzy A, Assal RA.   +6 more
europepmc   +1 more source

<i>Artemisia argyi</i>-enhanced Mesenchymal Stem Cell Exosomes Alleviates Inflammation in C28/I2 Chondrocytes by inhibiting NF-κB. [PDF]

Int J Med Sci
Kao SW, Hsu YT, Kuo WW, Huang TL, Lin KH, Kuo CH, Hsieh DJ, Ho TJ, Lin SZ, Huang CY.   +9 more
europepmc   +1 more source

Cannabidiol Suppresses EMT in Pancreatic Cancer via Inhibition of MALAT1 lncRNA and PI3K/Akt/mTOR Signaling Pathway. [PDF]

IUBMB Life
Kim NY, Jung YY, Um JY, Ahn KS.
europepmc   +1 more source

Macrophage migration inhibitory factor: Exploring physiological roles and comparing health benefits against oncogenic and autoimmune risks (Review). [PDF]

Int J Mol Med
Camacho Meza G, Avalos Navarro G, De La Cruz Mosso U, Ramírez Patiño R, Muñoz Valle JF, Bautista Herrera LA.   +5 more
europepmc   +1 more source

The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells. [PDF]

PLoS One
Russo D, Spina A, Portella L, Bello AM, Galdiero F, Trotta AM, Ieranò C, Rea G, Cecere SC, Coppola E, Di Maro S, Pignata S, Califano D, Scala S.   +13 more
europepmc   +1 more source

CXCR Family and Hematologic Malignancies in the Bone Marrow Microenvironment. [PDF]

Biomolecules
Liu Y, Tang H.
europepmc   +1 more source

Dual targeting of CXCR4 and EZH2 in endometriosis. [PDF]

iScience
Brunty S, Wagner K, Fleshman T, Ruley M, Mitchell B, Santanam N.   +5 more
europepmc   +1 more source

Chemokines and their receptors in the esophageal carcinoma tumor microenvironment: key factors for metastasis and progression. [PDF]

Front Oncol
Liu P, Sun Z.
europepmc   +1 more source

Unlocking the "undruggable": current landscape and emerging frontiers in lysosomal receptor-mediated protein degradation. [PDF]

Drug Deliv
Ma YM, Xia HF, Xiao YL, Yu ZL.
europepmc   +1 more source